Echo Therapeutics (ECTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,198 | -14,963 | -19,067 | -12,332 | -10,030 |
| Depreciation Amortization | 522 | 3,942 | 4,239 | 689 | 48 |
| Accounts receivable | N/A | N/A | N/A | 37 | 104 |
| Accounts payable and accrued liabilities | 657 | 765 | -1,283 | 1,954 | -240 |
| Other Working Capital | 815 | -177 | -1,456 | 2,763 | -12 |
| Other Operating Activity | 15,125 | -293 | -1,842 | -3,398 | 3,204 |
| Operating Cash Flow | $-5,080 | $-10,725 | $-19,410 | $-10,288 | $-6,926 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 70 | -37 | -249 | -1,487 | -323 |
| Other Investing Activity | -184 | 252 | 105 | -158 | 6 |
| Investing Cash Flow | $-114 | $215 | $-144 | $-1,645 | $-318 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 330 | N/A | N/A | 3,000 | 1,000 |
| Debt Repayment | N/A | -1 | -3,003 | -2 | -77 |
| Common Stock Issued | 3,582 | 3,293 | 26,865 | 3,686 | 13,974 |
| Other Financing Activity | 59 | 441 | 0 | 0 | 0 |
| Financing Cash Flow | $3,971 | $3,733 | $23,862 | $6,684 | $14,897 |
| Beginning Cash Position | 1,279 | 8,055 | 3,747 | 8,996 | 1,342 |
| End Cash Position | 56 | 1,279 | 8,055 | 3,747 | 8,996 |
| Net Cash Flow | $-1,223 | $-6,776 | $4,308 | $-5,248 | $7,654 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,080 | -10,725 | -19,410 | -10,288 | -6,926 |
| Capital Expenditure | -56 | -37 | -249 | -1,487 | -323 |
| Free Cash Flow | -5,136 | -10,761 | -19,659 | -11,775 | -7,249 |